Search

Your search keyword '"Cytomegalovirus immunology"' showing total 282 results

Search Constraints

Start Over You searched for: Descriptor "Cytomegalovirus immunology" Remove constraint Descriptor: "Cytomegalovirus immunology" Publisher lippincott williams & wilkins Remove constraint Publisher: lippincott williams & wilkins
282 results on '"Cytomegalovirus immunology"'

Search Results

1. Reexploring cytomegalovirus serology in allogeneic hematopoietic cell transplantation.

2. Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa.

3. Lifespan Socioeconomic Context Is Associated With Cytomegalovirus and Late-Differentiated CD8 + T and Natural Killer Cells: Initial Results in Older Adults.

4. Cytomegalovirus Infection Downregulates Vitamin D Receptor in Patients Undergoing Hematopoietic Stem Cell Transplantation.

5. Anticytomegalovirus CD4 + T Cells Are Associated With Subclinical Atherosclerosis in Persons With HIV.

6. Papillitis, a Rare Cytomegalovirus Manifestation in an Immunocompetent Host.

7. The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis.

8. Frequency of Cytomegalovirus Seropositivity and Viremia in a Midwestern University Lupus Population.

9. New Insights Into the Molecular Mechanisms and Immune Control of Cytomegalovirus Reactivation.

10. Cytomegalovirus-vectored vaccines for HIV and other pathogens.

11. Letermovir for Difficult to Treat Cytomegalovirus Infection in Lung Transplant Recipients.

12. Impact of CMV Reactivation, Treatment Approaches, and Immune Reconstitution in a Nonmyeloablative Tolerance Induction Protocol in Cynomolgus Macaques.

13. Cytomegalovirus Pneumonia Causing Acute Respiratory Distress Syndrome After Brentuximab Vedotin Therapy.

14. The immunity features and defects against primary cytomegalovirus infection post-splenectomy indicate an immunocompromised status: A PRISMA-compliant meta-analysis.

15. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.

16. Dimorphism in the T-cell receptor constant region affects T-cell function, phenotype and HIV outcome.

17. Development of a Predictive Model Using Endoscopic Features for Gastric Cytomegalovirus Infection in Renal Transplant Patients.

18. A Randomized Study of Quantiferon CMV-directed Versus Fixed-duration Valganciclovir Prophylaxis to Reduce Late CMV After Lung Transplantation.

19. Clinical Correlation of Cytomegalovirus Infection With CMV-specific CD8+ T-cell Immune Competence Score and Lymphocyte Subsets in Solid Organ Transplant Recipients.

20. Human cytomegalovirus-vectored vaccines against HIV.

21. CMV-specific Cell-mediated Immunity at 3-month Prophylaxis Withdrawal Discriminates D+/R+ Kidney Transplants at Risk of Late-onset CMV Infection Regardless the Type of Induction Therapy.

22. Anti-Cytomegalovirus Activity in Human Milk and Colostrum From Mothers of Preterm Infants.

23. Specific Immunity to Cytomegalovirus in Pediatric Cardiac Transplantation.

24. EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children.

25. Prevention and treatment of cytomegalovirus in immunocompromised patients: beyond DNA polymerase inhibition.

26. Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation.

27. Comparison of Preemptive Therapy and Antiviral Prophylaxis for Prevention of Cytomegalovirus in Seropositive Liver Transplant Recipients.

28. Clinical and Serological Predictors of Suicide in Schizophrenia and Major Mood Disorders.

29. Urinary CXCL10 Chemokine Is Associated With Alloimmune and Virus Compartment-Specific Renal Allograft Inflammation.

30. Cytomegalovirus encephalitis in the post-HAART era: is there a gold standard for treatment?

31. CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor.

32. Cytomegalovirus Immunity After Alemtuzumab Induction in Desensitized Kidney Transplant Patients.

34. A case report of lymphoid intestitial pneumonia in common variable immunodeficiency: Oligoclonal expansion of effector lymphocytes with preferential cytomegalovirus-specific immune response and lymphoproliferative disease promotion.

35. Human Cytomegalovirus-Encoded Receptor US28 Is Expressed in Renal Allografts and Facilitates Viral Spreading In Vitro.

36. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.

37. Cytomegalovirus-Specific T Cells Isolated by IFN-γ Secretion Assay Do Not Induce Significant Graft-Versus-Host Reactions In Vitro.

38. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.

39. Income and Markers of Immunological Cellular Aging.

40. The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV.

41. Cytomegalovirus Immunoglobulin After Thoracic Transplantation: An Overview.

42. Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.

43. CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients.

44. Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients.

45. Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation.

46. Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.

47. Cytomegalovirus.

48. A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients.

49. Immune resilience in HIV-infected individuals seronegative for cytomegalovirus.

50. Cytomegalovirus-specific responses of CD38⁺ memory T cells are skewed towards IFN-γ and dissociated from CD154 in HIV-1 infection.

Catalog

Books, media, physical & digital resources